LivaNova PLC
General ticker "LIVN" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $2.6B (TTM average)
LivaNova PLC follows the US Stock Market performance with the rate: 65.9%.
Estimated limits based on current volatility of 2.8%: low 62.98$, high 66.60$
Factors to consider:
- Total employees count: 2900 (0.0%) as of 2024
- US accounted for 57.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Geopolitical risks, Cybersecurity threats, Public health crises, Supply chain disruptions, Liquidity and credit risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [54.75$, 85.50$]
- 2026-12-31 to 2027-12-31 estimated range: [52.95$, 83.81$]
Financial Metrics affecting the LIVN estimates:
- Negative: with PPE of 17.4 at the end of fiscal year the price was high
- Positive: 7.67 < Operating profit margin, % of 14.36
- Positive: 6.64 < Operating cash flow per share per price, % of 7.45
- Positive: Inventory ratio change, % of 0.53 <= 0.80
- Positive: 42.68 < Shareholder equity ratio, % of 46.05 <= 64.29
- Negative: negative Net income
- Positive: -4.43 < Investing cash flow per share per price, % of -2.14
Short-term LIVN quotes
Long-term LIVN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,115.72MM | $1,220.39MM | $1,388.10MM |
| Operating Expenses | $1,184.21MM | $1,091.34MM | $1,188.70MM |
| Operating Income | $-68.50MM | $129.05MM | $199.40MM |
| Non-Operating Income | $-12.73MM | $-40.74MM | $-420.20MM |
| Interest Expense | $58.85MM | $63.07MM | $49.30MM |
| R&D Expense | $193.82MM | $182.51MM | $185.80MM |
| Income(Loss) | $-81.23MM | $88.31MM | $-220.80MM |
| Taxes | $-98.88MM | $25.06MM | $21.60MM |
| Other Income(Loss) | $-0.10MM | $-0.02MM | $0.00MM |
| Profit(Loss)* | $17.55MM | $63.22MM | $-242.50MM |
| Stockholders Equity | $1,277.63MM | $1,320.26MM | $1,200.00MM |
| Inventory | $147.89MM | $147.57MM | $164.70MM |
| Assets | $2,429.56MM | $2,506.39MM | $2,606.10MM |
| Operating Cash Flow | $74.91MM | $183.04MM | $254.30MM |
| Capital expenditure | $34.98MM | $47.11MM | $81.10MM |
| Investing Cash Flow | $-40.33MM | $-48.16MM | $-72.90MM |
| Financing Cash Flow | $21.48MM | $18.55MM | $-285.70MM |
| Earnings Per Share** | $0.33 | $1.17 | $-4.45 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.